Possible Bearish Signals With Henry Schein Insiders Disposing Stock
Many Henry Schein, Inc. (NASDAQ:HSIC) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether i
Henry Schein to Present at Investor Conferences in June 2024
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor
Why Henry Schein (HSIC) Is a Top Momentum Stock for the Long-Term
Henry Schein Mobilizes Support for Recovery Efforts in Brazil
Company Commits Over $200,000 in Cash and Health Care Product Donations, Matches Employee Contributions In the wake of the devastation caused by the flooding in Brazil, Henry Schein, Inc. (NASDAQ:HSIC) is raising
Looking Into Henry Schein's Recent Short Interest
Henry Schein's (NYSE:HSIC) short percent of float has fallen 4.69% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 4.67% of all regular shares
Henry Schein Extends Partnership With Special Olympics Through 2025, Promoting Wellness and Health Education for Athletes With Intellectual Disabilities Around the World
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has extended through 2025 its existing partnership with
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $92
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price target from $90 to $92.
Lucas Systems Announces 100 Billion Warehouse Picks
Credits Continuous Innovation of Technologies Centered Around WorkersWEXFORD, Pa., May 8, 2024 /PRNewswire/ -- Warehouse workers made 100 billion warehouse picks using Lucas Systems software, accordi
UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating
Henry Schein (HSIC) has an average hold rating and price target range of $65 to $90, according to analysts polled by Capital IQ. Price: 73.67, Change: +2.47, Percent Change: +3.46
Henry Schein Price Target Cut to $80.00/Share From $82.00 by UBS
Henry Schein Price Target Cut to $80.00/Share From $82.00 by UBS
Henry Schein Is Maintained at Neutral by UBS
Henry Schein Is Maintained at Neutral by UBS
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $82 to $80.
Henry Schein Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 12.44% UBS $82 → $80 Maintains Neutral 03/06/2024 23.68% JP Morgan $82 → $88 Maintains Overweig
Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC) and Esperion (ESPR)
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Henry Schein, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target price by $3
Goldman Sachs Adjusts Price Target on Henry Schein to $74 From $76
Henry Schein (HSIC) has an average rating of hold and price targets ranging from $65 to $90, according to analysts polled by Capital IQ.
Baird Adjusts Price Target on Henry Schein to $81 From $83, Maintains Neutral Rating
Henry Schein (HSIC) has an average rating of hold and price targets ranging from $65 to $90, according to analysts polled by Capital IQ.
No Data